Stockreport

Mainz Biomed Announces 6.0 USD Million Private Placement and Strategic Update

Mainz Biomed B.V.  (MYNZ) 
PDF BERKELEY, Calif. and MAINZ, Germany, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ: MYNZ), a molecular genetics diagnostic company specializing in the ea [Read more]